Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Metab ; 30(3): 447-461.e5, 2019 09 03.
Article in English | MEDLINE | ID: mdl-31378464

ABSTRACT

Mechanisms that regulate metabolites and downstream energy generation are key determinants of T cell cytokine production, but the processes underlying the Th17 profile that predicts the metabolic status of people with obesity are untested. Th17 function requires fatty acid uptake, and our new data show that blockade of CPT1A inhibits Th17-associated cytokine production by cells from people with type 2 diabetes (T2D). A low CACT:CPT1A ratio in immune cells from T2D subjects indicates altered mitochondrial function and coincides with the preference of these cells to generate ATP through glycolysis rather than fatty acid oxidation. However, glycolysis was not critical for Th17 cytokines. Instead, ß oxidation blockade or CACT knockdown in T cells from lean subjects to mimic characteristics of T2D causes cells to utilize 16C-fatty acylcarnitine to support Th17 cytokines. These data show long-chain acylcarnitine combines with compromised ß oxidation to promote disease-predictive inflammation in human T2D.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Fatty Acids/metabolism , Lymphocyte Activation/immunology , Th17 Cells/immunology , Adult , Aged , Carnitine/analogs & derivatives , Carnitine/metabolism , Carnitine O-Palmitoyltransferase/genetics , Cells, Cultured , Cross-Sectional Studies , Cytokines/metabolism , Female , Gene Knockdown Techniques , Glycolysis/genetics , Humans , Inflammation/metabolism , Male , Membrane Transport Proteins/genetics , Middle Aged , Obesity/metabolism , Oxidation-Reduction , Transfection , Young Adult
2.
PLoS One ; 12(12): e0188474, 2017.
Article in English | MEDLINE | ID: mdl-29206239

ABSTRACT

Triggers of the autoimmune response that leads to type 1 diabetes (T1D) remain poorly understood. A possibility is that parallel changes in both T cells and target cells provoke autoimmune attack. We previously documented greater Ca2+ transients in fibroblasts from T1D subjects than non-T1D after exposure to fatty acids (FA) and tumor necrosis factor α (TNFα). These data indicate that metabolic and signal transduction defects present in T1D can be elicited ex vivo in isolated cells. Changes that precede T1D, including inflammation, may activate atypical responses in people that are genetically predisposed to T1D. To identify such cellular differences in T1D, we quantified a panel of metabolic responses in fibroblasts and peripheral blood cells (PBMCs) from age-matched T1D and non-T1D subjects, as models for non-immune and immune cells, respectively. Fibroblasts from T1D subjects accumulated more lipid, had higher LC-CoA levels and converted more FA to CO2, with less mitochondrial proton leak in response to oleate alone or with TNFα, using the latter as a model of inflammation. T1D-PBMCs contained and also accumulated more lipid following FA exposure. In addition, they formed more peroxidized lipid than controls following FA exposure. We conclude that both immune and non-immune cells in T1D subjects differ from controls in terms of responses to FA and TNFα. Our results suggest a differential sensitivity to inflammatory insults and FA that may precede and contribute to T1D by priming both immune cells and their targets for autoimmune reactions.


Subject(s)
Diabetes Mellitus, Type 1/metabolism , Leukocytes, Mononuclear/metabolism , Lipid Metabolism , Adenosine Triphosphate/metabolism , Fibroblasts/metabolism , Humans , Lipid Peroxidation , Oleic Acid , Oxidation-Reduction , Oxygen Consumption , Tumor Necrosis Factor-alpha/metabolism
3.
PLoS One ; 11(10): e0164011, 2016.
Article in English | MEDLINE | ID: mdl-27741233

ABSTRACT

BACKGROUND: Many tissues play an important role in metabolic homeostasis and the development of diabetes and obesity. We hypothesized that the circulating redox metabolome is a master metabolic regulatory system that impacts all organs and modulates reactive oxygen species (ROS) production, lipid peroxidation, energy production and changes in lipid turnover in many cells including adipocytes. METHODS: Differentiated human preadipocytes were exposed to the redox couples, lactate (L) and pyruvate (P), ß-hydroxybutyrate (ßOHB) and acetoacetate (Acoc), and the thiol-disulfides cysteine/ cystine (Cys/CySS) and GSH/GSSG for 1.5-4 hours. ROS measurements were done with CM-H2DCFDA. Lipid peroxidation (LPO) was assessed by a modification of the thiobarbituric acid method. Lipolysis was measured as glycerol release. Lipid synthesis was measured as 14C-glucose incorporated into lipid. Respiration was assessed using the SeaHorse XF24 analyzer and the proton leak was determined from the difference in respiration with oligomycin and antimycin A. RESULTS: Metabolites with increasing oxidation potentials (GSSG, CySS, Acoc) increased adipocyte ROS. In contrast, P caused a decrease in ROS compared with L. Acoc also induced a significant increase in both LPO and lipid synthesis. L and Acoc increased lipolysis. ßOHB increased respiration, mainly due to an increased proton leak. GSSG, when present throughout 14 days of differentiation significantly increased fat accumulation, but not when added later. CONCLUSIONS: We demonstrated that in human adipocytes changes in the external redox state impacted ROS production, LPO, energy efficiency, lipid handling, and differentiation. A more oxidized state generally led to increased ROS, LPO and lipid turnover and more reduction led to increased respiration and a proton leak. However, not all of the redox couples were the same suggesting compartmentalization. These data are consistent with the concept of the circulating redox metabolome as a master metabolic regulatory system.


Subject(s)
Mitochondria/metabolism , Reactive Oxygen Species/metabolism , 3-Hydroxybutyric Acid/pharmacology , Acetoacetates/pharmacology , Adipocytes/cytology , Adipocytes/metabolism , Cell Differentiation/drug effects , Cells, Cultured , Colforsin/pharmacology , Cysteine/metabolism , Glucose/pharmacology , Glutathione/metabolism , Glycerol/metabolism , Humans , Ketone Bodies/pharmacology , Lactates/metabolism , Lipid Peroxidation/drug effects , Lipogenesis/drug effects , Oxidation-Reduction , Oxygen Consumption
4.
PLoS One ; 9(1): e87068, 2014.
Article in English | MEDLINE | ID: mdl-24466329

ABSTRACT

The effects of cytokine and fatty acid treatment on signal transduction in dermal fibroblasts from type 1 diabetics and matched controls were compared. Chronic exposure to TNF, accentuated Ca(2+) mobilization in response to bradykinin (BK) in cells from both controls and diabetics; responses were three-fold greater in cells from diabetics than in controls. Similarly, with chronic exposure to IL-1ß, BK-induced Ca(2+) mobilization was accentuated in cells from type 1 diabetics compared to the controls. Pretreatment with the protein synthesis inhibitor cycloheximide or the protein kinase C inhibitor calphostin C prior to the addition of TNF completely abrogated the TNF-induced increment in peak bradykinin response. Ca(2+) transients induced by depleting endoplasmic reticulum (ER) Ca(2+) with thapsigargin were also greater in TNF treated fibroblasts than in untreated cells, with greater increases in cells from diabetics. Exposing fibroblasts for 48 hours to 2 mM oleate also increased both the peak bradykinin response and the TNF-induced increment in peak response, which were significantly greater in diabetics than controls. These data indicate that cells from diabetic patients acquire elevated ER Ca(2+) stores in response to both cytokines and free fatty acids,and thus exhibit greater sensitivity to environmental inflammatory stimuli and elevated lipids.


Subject(s)
Calcium/metabolism , Dermis/metabolism , Diabetes Mellitus, Type 1/metabolism , Fatty Acids, Nonesterified/pharmacology , Fibroblasts/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Blotting, Western , Bradykinin/metabolism , Case-Control Studies , Cells, Cultured , Cytokines/metabolism , Dermis/cytology , Dermis/drug effects , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/pathology , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/metabolism , Enzyme Inhibitors/pharmacology , Fibroblasts/cytology , Fibroblasts/drug effects , Humans , Interleukin-1/metabolism , Receptors, Bradykinin/metabolism , Siblings , Signal Transduction , Thapsigargin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...